Clinical Science Research
The Bass Center for Childhood Cancer and Blood Disorders at Stanford Children's Health | Lucile Packard Children's Hospital at Stanford has world-renowned research programs dedicated to developing new treatments for cancers and blood diseases that affect children.
Our physicians and researchers hold leadership roles in the Children's Oncology Group (COG). The Children's Oncology Group is a national clinical research consortium made up of more than 200 pediatric cancer centers, which designs and evaluates cancer therapies through large clinical trials. Because we are a participating Center, all of our patients are eligible for treatment protocols used by this respected national research cooperative. Clinical trials allow our patients access to promising treatments still in development. The Center has an average of 75 active clinical trials available to eligible patients.
Our clinical research includes Phase I, II and III clinical trials investigating experimental therapies and new agents that reduce toxicity of chemotherapies. Our team also works closely with researchers at the Stanford School of Medicine in genetic profiling of tumors, new drug development and genetic targets for therapies.
Innovation & Clinical Research
Click here to read more detailed information about innovation and clinical research that is taking place at the Bass Center for Childhood Cancer and Blood Disorders.